DRC Balatongyorok
About DRC Balatongyorok
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at DRC Balatongyorok
During the past decade, DRC Balatongyorok conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
2003-07-01
Completed
860
An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus
2007-03-01
2009-03-01
Unknown status
40
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
2005-07-01
2008-06-01
Completed
42
Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load
2009-09-01
2012-12-01
Terminated
59
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT
2008-09-01
2015-05-01
Unknown status
130
Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
2014-01-20
2015-12-18
Completed
422
Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
2013-08-01
2016-04-01
Completed
395
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at DRC Balatongyorok
According to Clinical.Site data, the most researched conditions in "DRC Balatongyorok" are
"Cardiovascular Disease" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "DRC Balatongyorok" in a lesser frequency.
Clinical Trials Intervention Types at DRC Balatongyorok
Most popular intervention types in "DRC Balatongyorok" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo" (2 trials), "Placebo (for K-877)" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at DRC Balatongyorok
The vast majority of trials in "DRC Balatongyorok" are
4 trials for "All" genders.
Clinical Trials Status at DRC Balatongyorok
Currently, there are NaN active trials in "DRC Balatongyorok".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in DRC Balatongyorok,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in DRC Balatongyorok, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".